Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma
Authors:
Open Access
- 14 May 2020
- journal article
- research article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 39 (1) , 1-15
Abstract
Background: Overexpression of survivin plays a crucial role in tumorigenesis and correlates with poor prognosis in human malignancies. Thus, survivin has been proposed as an attractive target for new anti-tumor interventions. Methods: A natural product library was used for natural compound screening through MTS assay. The expression of survivin in oral squamous cell carcinoma (OSCC) and the inhibitory effect of xanthohumol (XN) on OSCC were examined by anchorage-dependent and -independent growth assays, immunoblot, immunofluorescence, immunohistochemical staining, ubiquitination analysis, co-immunoprecipitation assay, CRISPR-Cas9-based gene knockout, and xenograft experiment. Results: Survivin is highly expressed in OSCC patient-derived tissues and cell lines. Knockout of survivin reduced the tumorigenic properties of OSCC cells in vitro and in vivo. With a natural compound screening, we identified that xanthohumol inhibited OSCC cells by reducing survivin protein level and activating mitochondrial apoptotic signaling. Xanthohumol inhibited the Akt-Wee1-CDK1 signaling, which in turn decreased survivin phosphorylation on Thr34, and facilitated E3 ligase Fbxl7-mediated survivin ubiquitination and degradation. Xanthohumol alone or in combination with radiation overcame radioresistance in OSCC xenograft tumors. Conclusion: Our findings indicate that targeting survivin for degradation might a promising strategy for OSCC treatment.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81904262, 81972837)
- Natural Science Foundation of Hunan Province (2018JJ3787, 2018JJ2604, 2019JJ50682)
This publication has 53 references indexed in Scilit:
- Survivin as a Preferential Target for Cancer TherapyInternational Journal of Molecular Sciences, 2014
- Transcriptional regulation of the survivin geneMolecular Biology Reports, 2013
- Survivin – biology and potential as a therapeutic target in oncologyOncoTargets and Therapy, 2013
- Fungal metabolites of xanthohumol with potent antiproliferative activity on human cancer cell lines in vitroBioorganic & Medicinal Chemistry, 2013
- Survivin-T34A: molecular mechanism and therapeutic potentialOncoTargets and Therapy, 2010
- Nuclear Survivin Has Reduced Stability and Is Not CytoprotectiveJournal of Biological Chemistry, 2008
- Degradation of Survivin by the X-linked Inhibitor of Apoptosis (XIAP)-XAF1 ComplexJournal of Biological Chemistry, 2007
- YM155, a Novel Small-Molecule Survivin Suppressant, Induces Regression of Established Human Hormone-Refractory Prostate Tumor XenograftsCancer Research, 2007
- Chromosome Alignment and Segregation Regulated by Ubiquitination of SurvivinScience, 2005
- Akt/Protein Kinase B-Dependent Phosphorylation and Inactivation of WEE1Hu Promote Cell Cycle Progression at G2/M TransitionMolecular and Cellular Biology, 2005